321 related articles for article (PubMed ID: 24655685)
21. Reflections on the evolution of health technology assessment in Europe.
Sorenson C; Chalkidou K
Health Econ Policy Law; 2012 Jan; 7(1):25-45. PubMed ID: 22221927
[TBL] [Abstract][Full Text] [Related]
22. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
Oortwijn W; Mathijssen J; Banta D
Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
[TBL] [Abstract][Full Text] [Related]
23. Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening.
Potter BK; Avard D; Graham ID; Entwistle VA; Caulfield TA; Chakraborty P; Kennedy C; McGuire M; Griener GG; Montgomery M; Wells GA; Wilson BJ
Int J Technol Assess Health Care; 2008; 24(4):412-22. PubMed ID: 18828935
[TBL] [Abstract][Full Text] [Related]
24. Addressing the health technology assessment of biosimilar pharmaceuticals.
Stewart A; Aubrey P; Belsey J
Curr Med Res Opin; 2010 Sep; 26(9):2119-26. PubMed ID: 20649394
[TBL] [Abstract][Full Text] [Related]
25. Health technology assessment.
Hailey D
Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
[TBL] [Abstract][Full Text] [Related]
26. A history of health technology assessment at the European level.
Banta D; Kristensen FB; Jonsson E
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():68-73. PubMed ID: 19534837
[TBL] [Abstract][Full Text] [Related]
27. History of health technology assessment: Spain.
Sampietro-Colom L; Asua J; Briones E; Gol J;
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():163-73. PubMed ID: 19538814
[TBL] [Abstract][Full Text] [Related]
28. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies.
Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
Soc Sci Med; 2010 May; 70(10):1518-26. PubMed ID: 20207061
[TBL] [Abstract][Full Text] [Related]
29. Health technology assessment in Denmark: strategy, implementation, and developments.
Sigmund H; Kristensen FB
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():94-101. PubMed ID: 19505351
[TBL] [Abstract][Full Text] [Related]
30. Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities.
Henshall C; Mardhani-Bayne L; Frønsdal KB; Klemp M
Int J Technol Assess Health Care; 2011 Jul; 27(3):253-60. PubMed ID: 21756413
[TBL] [Abstract][Full Text] [Related]
31. Health technology assessment and priority setting for health policy in Sweden.
Carlsson P
Int J Technol Assess Health Care; 2004; 20(1):44-54. PubMed ID: 15176176
[TBL] [Abstract][Full Text] [Related]
32. Development of health technology assessment in Lithuania.
Danguole J
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():140-2. PubMed ID: 19575824
[TBL] [Abstract][Full Text] [Related]
33. Systems to support health technology assessment (HTA) in member states of the European union with limited institutionalization of HTA.
Moharra M; Espallargues M; Kubesch N; Estrada MD; Parada A; Vondeling H; Lo Scalzo A; Cristofides S; Turk E; Raab M;
Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():75-83. PubMed ID: 20030894
[TBL] [Abstract][Full Text] [Related]
34. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.
Frønsdal KB; Facey K; Klemp M; Norderhaug IN; Mørland B; Røttingen JA
Int J Technol Assess Health Care; 2010 Jul; 26(3):309-16. PubMed ID: 20584360
[TBL] [Abstract][Full Text] [Related]
35. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
[TBL] [Abstract][Full Text] [Related]
36. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
Kahveci R; Koç EM; Küçük EÖ
Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
[TBL] [Abstract][Full Text] [Related]
37. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
38. HTA and its legal issues: a framework for identifying legal issues in health technology assessment.
Widrig D; Tag B
Int J Technol Assess Health Care; 2014 Dec; 30(6):587-94. PubMed ID: 25816824
[TBL] [Abstract][Full Text] [Related]
39. A SWOT analysis of the development of health technology assessment in Iran.
Behzadifar M; Ghanbari MK; Azari S; Bakhtiari A; Rahimi S; Ehsanzadeh SJ; Sharafkhani N; Moridi S; Bragazzi NL
PLoS One; 2023; 18(3):e0283663. PubMed ID: 36996128
[TBL] [Abstract][Full Text] [Related]
40. Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.
Lehoux P; Miller FA; Daudelin G; Denis JL
Int J Health Policy Manag; 2017 Sep; 6(9):509-518. PubMed ID: 28949463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
